V8639

VO-OHpic

≥98% (HPLC), solid

• Sinonimo/i: (OC-6-45) Aqua (3-hydroxy-2-pyridinecarboxylato-kapaN1,kapaO2)[3-(hydroxy-kapaO)-2-pyridinecarboxylato(2-)-kapaO2]oxo-vanadate(1-), hydrogen,
• Formula empirica (notazione di Hill): C₁₂H₉N₂O₈V · H · 3H₂O
• Numero CAS: 476310-60-8
• Peso molecolare: 415.20
• UNSPSC Code: 41121801
• PubChem Substance ID: 329829435
• NACRES: NA.77
• Assay: ≥98% (HPLC)
• Form: solid

Proprietà

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: solid
• color: gray
• solubility: DMSO: >10 mg/mL
• storage temp.: −20°C
• SMILES string: O.O.O.O.Oc1cccnc1C(=O)O[VH]2(=O)OC(=O)c3cccnc3O2
• InChI: 1S/2C6H5NO3.4H2O.O.V.H/c2*8-4-2-1-3-7-5(4)6(9)10;;;;;;;/h2*1-3,8H,(H,9,10);4*1H2;;;/q;;;;;;;+3;/p-3
• InChI key: QVBVJWFAUFEGMT-UHFFFAOYSA-K

Descrizione

General description

VO-OHpic is a vanadium complex. VO-OHpic might act as a possible pro-senescence anti-cancer drug for treating cancers with reduced phosphatase and tensin homolog (PTEN) expression. It blocks cell viability, cell proliferation, colony formation and induced senescence-associated β-galactosidase activity in Hep3B cells.

Application

VO-OHpic trihydrate has been used in studying the role of phosphatase and tensin homolog (PTEN) in polycomb repressive complex 2 (PRC2)-mediated apoptosis. It also has been used as a PTEN inhibitor to study the neuroprotective effect of melatonin in amyloid beta (Aβ)-induced neurotoxicity via PTEN pathway.

Biochem/physiol Actions

VO-OHpic trihydrate is a PTEN (phosphatase and tensin homologue deleted on chromosome 10) inhibitor.

Informazioni sulla sicurezza

• Classe di stoccaggio: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable